These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23548494)

  • 1. Differences between users and non-users of complementary and alternative medicine among people with multiple sclerosis in Denmark: a comparison of descriptive characteristics.
    Skovgaard L; Nicolajsen PH; Pedersen E; Kant M; Fredrikson S; Verhoef M; Meyrowitsch D
    Scand J Public Health; 2013 Jul; 41(5):492-9. PubMed ID: 23548494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer.
    Pedersen CG; Christensen S; Jensen AB; Zachariae R
    Eur J Cancer; 2009 Dec; 45(18):3172-81. PubMed ID: 19811905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How frequently do patients with multiple sclerosis use complementary and alternative medicine?
    Apel A; Greim B; Zettl UK
    Complement Ther Med; 2005 Dec; 13(4):258-63. PubMed ID: 16338196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of complementary and alternative therapies by people with multiple sclerosis.
    Page SA; Verhoef MJ; Stebbins RA; Metz LM; Levy JC
    Chronic Dis Can; 2003; 24(2-3):75-9. PubMed ID: 12959678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and users of complementary and alternative medicine among people with multiple sclerosis in Denmark.
    Skovgaard L
    Dan Med J; 2016 Jan; 63(1):B5159. PubMed ID: 26726906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary and alternative medicine use among health plan members. A cross-sectional survey.
    Gray CM; Tan AW; Pronk NP; O'Connor PJ
    Eff Clin Pract; 2002; 5(1):17-22. PubMed ID: 11878283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary and alternative medicine (CAM) among hospitalised patients: reported use of CAM and reasons for use, CAM preferred during hospitalisation, and the socio-demographic determinants of CAM users.
    Shorofi SA
    Complement Ther Clin Pract; 2011 Nov; 17(4):199-205. PubMed ID: 21982133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of complementary medicinal therapies in West Pomerania: a population-based study.
    Schwarz S; Messerschmidt H; Völzke H; Hoffmann W; Lucht M; Dören M
    Climacteric; 2008 Apr; 11(2):124-34. PubMed ID: 18365855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health service use amongst users of complementary and alternative medicine.
    Pledger MJ; Cumming JN; Burnette M
    N Z Med J; 2010 Apr; 123(1312):26-35. PubMed ID: 20389315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Care Activities among People with Multiple Sclerosis in Denmark: Use and User Characteristics.
    Lynning M; Hanehøj K; Karnøe Knudsen A; Skovgaard L
    Complement Med Res; 2017; 24(4):240-245. PubMed ID: 28743104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alternative therapies in Denmark--use, users and motives for the use].
    Lønroth HL; Ekholm O
    Ugeskr Laeger; 2006 Feb; 168(7):682-6. PubMed ID: 16494807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of complementary and alternative medicine (CAM) by people with multiple sclerosis.
    Olsen SA
    Occup Ther Int; 2009; 16(1):57-70. PubMed ID: 19222053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of complementary and alternative medicine in healthy children and children with chronic medical conditions in Germany.
    Gottschling S; Gronwald B; Schmitt S; Schmitt C; Längler A; Leidig E; Meyer S; Baan A; Shamdeen MG; Berrang J; Graf N
    Complement Ther Med; 2013 Apr; 21 Suppl 1():S61-9. PubMed ID: 23578919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of alternative and complementary therapies in children with cancer.
    Martel D; Bussières JF; Théorêt Y; Lebel D; Kish S; Moghrabi A; Laurier C
    Pediatr Blood Cancer; 2005 Jun; 44(7):660-8. PubMed ID: 15714446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of complementary and alternative medicine practitioners by people with physical disabilities: estimates from a National US Survey.
    Carlson MJ; Krahn G
    Disabil Rehabil; 2006 Apr; 28(8):505-13. PubMed ID: 16513583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer.
    Wyatt G; Sikorskii A; Wills CE; Su H
    Nurs Res; 2010; 59(1):58-66. PubMed ID: 20010046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health status and health care utilisation of patients in complementary and conventional primary care in Switzerland--an observational study.
    Busato A; Dönges A; Herren S; Widmer M; Marian F
    Fam Pract; 2006 Feb; 23(1):116-24. PubMed ID: 16115833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary and alternative medicine for multiple sclerosis.
    Schwarz S; Knorr C; Geiger H; Flachenecker P
    Mult Scler; 2008 Sep; 14(8):1113-9. PubMed ID: 18632773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of complementary and alternative treatment for allergic contact dermatitis.
    Noiesen E; Munk MD; Larsen K; Høyen M; Agner T
    Br J Dermatol; 2007 Aug; 157(2):301-5. PubMed ID: 17573876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why?
    Leong EM; Semple SJ; Angley M; Siebert W; Petkov J; McKinnon RA
    Complement Ther Med; 2009 Aug; 17(4):216-23. PubMed ID: 19632549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.